Vitamin D and Immunity: Photosynthesis Versus Supplementation
IMMUNI-D
1 other identifier
interventional
36
0 countries
N/A
Brief Summary
The optimal way to restore serum 25-hydroxyvitamin D sufficiency is currently debatable. UV irradiation through sunshine exposure promotes endogenous vitamin D synthesis, although this can also be associated with a risk of UVR-induced skin cancer. Dietary supplements represent an alternative, which are increasingly being used in clinical trials to correct deficiency. However, it is unclear whether sunshine exposure and vitamin D supplementation induce comparable changes in immune function, or whether additional UVR-induced molecules may be responsible for proposed health benefits. Several studies report an inverse correlation between exposure to UVR and immune-mediated diseases, further supporting the theory that UVR may also be protective through non vitamin-D mediated pathways. So far it has been difficult to distinguish between immune-regulation by vitamin D and other mediators induced by UVR as the downstream effects are similar. A direct comparison of the biological effects of vitamin D obtained by UVR versus supplementation has never been made. This study aims to elucidate the differences in vitamin D generated by UVR exposure versus supplementation by comparing immunological endpoints
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 19, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2017
CompletedFirst Submitted
Initial submission to the registry
June 22, 2018
CompletedFirst Posted
Study publicly available on registry
August 1, 2018
CompletedAugust 1, 2018
July 1, 2018
1.4 years
June 22, 2018
July 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vitamin D status of healthy participants treated with oral vitamin D (cholecalciferol) or UVR (SSR) exposures and control (untreated)
Measure 25(OH)D3nmol/L via LC-MS/MS
3 years
Secondary Outcomes (3)
Changes to peripheral blood cell frequency
3 years
Impact upon the frequency and phenotype of peripheral blood dendritic cells
3 years
Gene expression in peripheral blood myeloid and plasmacytoid dendritic cells
3 years
Study Arms (3)
Control
NO INTERVENTIONNo intervention
UVR (Solar simulated radiation)
EXPERIMENTALTwice weekly 1.25 SED (sub-erythemal) (4 weeks)
Vitamin D3 supplementation
EXPERIMENTAL4X 1000IU cholecalciferol tablets daily (28 days)
Interventions
1.25 SED Solar simulated radiation twice weekly
Eligibility Criteria
You may qualify if:
- Age: 18-40
- Fitzpatrick skin type I/II
- Healthy
- Serum 25(OH)D3 \<50nmol/L
You may not qualify if:
- Serum 25(OH)D3 \>50nmol/L
- Pregnant or nursing women
- Women of child bearing age not using adequate contraception
- Are taking photosensitizing medication (i.e. causes you to be more sensitive to sunlight)
- Have had a history of skin disorders, sensitive skin, sensitivity to sunlight or skin cancer
- Have previously had an organ transplant
- Have partaken in a clinical study within the last 14 days
- Have had recent exposure to sunbeds (last 4 months) or holiday sun (including skiing)
- Are currently or have taken vitamin D supplements in the last 4 months Are asthmatic or suffer from any allergies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antony Young
King's College London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2018
First Posted
August 1, 2018
Study Start
November 19, 2015
Primary Completion
April 14, 2017
Study Completion
April 14, 2017
Last Updated
August 1, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share